Summary

The FDA has proposed removing oral phenylephrine, a common ingredient in over-the-counter cold medicines like NyQuil and Sudafed, due to evidence that it is ineffective as a nasal decongestant.

The proposal follows a unanimous vote by FDA advisers last year, and recent studies showing less than 1% of the drug is absorbed into the bloodstream when taken orally.

The public comment period ends on May 7, after which the FDA may finalize the ban.

  • ℍ𝕂-𝟞𝟝@sopuli.xyz
    link
    fedilink
    English
    arrow-up
    3
    arrow-down
    2
    ·
    2 months ago

    Sooo I see the thread is full of US people here and it’s so strange. I don’t have drug brand preferences. I go to my doctor, my doctor tells me what to take, I go to the pharmacy, they give it to me, and I take it as instructed.

    Am I missing out on anything?

    • WolfLink@sh.itjust.works
      link
      fedilink
      arrow-up
      13
      ·
      2 months ago

      These are over-the counter cough suppressants that you buy from the store without ever needing to see a doctor.

      • ℍ𝕂-𝟞𝟝@sopuli.xyz
        link
        fedilink
        English
        arrow-up
        3
        arrow-down
        1
        ·
        2 months ago

        I still usually call my doctor for OTC stuff, and if my doctor says I need it, insurance gets to pay for it. Going to the doctor usually saves me money. And if I schedule it during a workday, it’s not my time going either but my employer’s, if it even needs more than a phone consult.

        • M0oP0o@mander.xyz
          link
          fedilink
          arrow-up
          4
          ·
          1 month ago

          Well look at fancy pants over here with a Doctor.

          (Really here in Canada I have been without a Dr for about 9 years now, it sucks)

    • GreyEyedGhost@lemmy.ca
      link
      fedilink
      arrow-up
      6
      arrow-down
      1
      ·
      2 months ago

      You’re missing out on a lot of ads telling you how much you need to ask your doctor for certain drugs. That’s about it.